Feasibility Study of RapidPulseTM Aspiration System as Frontline Approach for Patients With Acute Ischemic Stroke (PULSE-F)
PULSE-F: Feasibility Study of RapidPulseTM Aspiration System as Frontline Approach for Patients With Acute Ischemic Stroke Due to Large Vessel Occlusions
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Cynthia Yang
- Phone Number: 9498367402
- Email: cyang@rapidpulsemed.com
Study Locations
-
-
-
Tbilisi, Georgia
- National Institute of Surgery
-
Tbilisi, Georgia
- Pineo Medical Ecosystems
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18 years or older
- Clinical diagnosis of acute ischemic stroke with symptom onset (or last seen normal) within 24 hours
- Large vessel occlusion (LVO) involving the intracranial internal carotid artery (ICA), middle cerebral artery (MCA) M1 or M2 segments, basilar or vertebral artery
- Target occlusion can be accessed by the Medtronic React 71 aspiration catheter
Exclusion Criteria:
- Known or suspected intracranial atherosclerotic disease (ICAD)
- Tandem occlusions
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Treatment Arm
Each subject will undergo baseline evaluation for acute ischemic stroke due to large vessel occlusion, per standard of care and undergo mechanical thrombectomy procedure, aspiration to remove thrombus in the neuro-vasculature using the RapidPulseTM (feasibility) device.
|
The RapidPulseTM Aspiration System paired with a single-use, disposable tubing set specific for use with the RapidPulseTM Aspiration System
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
First Pass Reperfusion Effect (FPE)
Time Frame: Intra-procedural
|
Defined by mTICI greater than or equal to 2c after one reperfusion attempt
|
Intra-procedural
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frontline Technical Success
Time Frame: Intra-procedural
|
As defined by mTICI 2b or greater after the last pass with Study Device (no rescue therapy)
|
Intra-procedural
|
|
Final mTICI
Time Frame: Intra-procedural
|
After all passes (including any rescue therapy)
|
Intra-procedural
|
|
Modified First Pass Reperfusion Effect (mFPE)
Time Frame: Intra-procedural
|
Defined as mTICI 2b or greater after one device pass
|
Intra-procedural
|
|
Device-related and procedure-related adverse events
Time Frame: Intra and post-procedural (up to 24 hours)
|
Including vessel injury, distal emboli, emboli in new territory (ENT) and vessel spasm
|
Intra and post-procedural (up to 24 hours)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Raul G Nogueira, MD, University of Pittsburgh Medical Center Stroke Institute
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CIP-0004
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.